Zakrowski Donald A

Avg. Two Year Performance

No purchase track record
(16%) Avg. Sale Return
(8%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)(5%)(7%)(8%)(16%)
Sale Success Rate5 of 133 of 133 of 133 of 130 of 13
Drugs » Drug Manufacturers - Major

Chief Accounting Officer:

Holdings: 7.65K shares

Sentiment

Insider Trading Sentiment: Strong Sell

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($544.14K) Net Amount
Buy:0--
Sell:($544.14K)$181.38